GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nexstim Oyj (OHEL:NXTMH) » Definitions » Asset Impairment Charge

Nexstim Oyj (OHEL:NXTMH) Asset Impairment Charge : €0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Nexstim Oyj Asset Impairment Charge?

Nexstim Oyj's Asset Impairment Charge for the six months ended in Dec. 2023 was €0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00 Mil.


Nexstim Oyj Asset Impairment Charge Historical Data

The historical data trend for Nexstim Oyj's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nexstim Oyj Asset Impairment Charge Chart

Nexstim Oyj Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Nexstim Oyj Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Nexstim Oyj Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.


Nexstim Oyj Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Nexstim Oyj's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.


Nexstim Oyj (OHEL:NXTMH) Business Description

Traded in Other Exchanges
Address
Elimaenkatu 9 B, Helsinki, FIN, FI-00510
Nexstim Oyj is medical technology company. The company has developed a non-invasive brain stimulation technology for navigated transcranial magnetic stimulation (nTMS) with 3D navigation providing accurate and personalized targeting of TMS to the specific area of the brain. The company earns revenue in Finland, Rest of Europe, North America and Other. The majority of revenue is earned in Finland.

Nexstim Oyj (OHEL:NXTMH) Headlines

No Headlines